cimetidine vs rosiglitazone

PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.

Side-by-side comparison of cimetidine and rosiglitazone. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

[See Clinical Pharmacology (12.4).] 7.2 Cationic Drugs Although drug interactions for metformin with cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, and vancomycin) remain theoretical (except for cimetidine), careful patient monitoring and dose adjustment of AVANDAMET and/or the interfering drug is recommended in patients who are taking cationic medications that are excreted via the proximal renal tubular secretory system.

Drug Class
cimetidine H2 Receptor Antagonist
rosiglitazone Thiazolidinedione
Type
cimetidine Over-the-Counter
rosiglitazone Prescription
Summary
cimetidine

Cimetidine (Tagamet) reduces stomach acid. It is used to treat ulcers, heartburn, and other conditions where too much acid is produced.

rosiglitazone

No summary available.

What It Treats
cimetidine

Cimetidine treats active duodenal ulcers for short periods. It can also be used long-term at a lower dose to prevent ulcers from returning. This medicine also treats active benign gastric ulcers for a short time. Additionally, it can help with erosive gastroesophageal reflux disease (GERD), which damages the esophagus.

rosiglitazone

Information not available.

How It Works
cimetidine

Cimetidine is an H2 receptor antagonist. This means it blocks histamine from attaching to certain cells in your stomach. By blocking histamine, cimetidine reduces the amount of acid your stomach makes.

rosiglitazone

Information not available.

Common Side Effects
cimetidine
  • Headache
  • Dizziness
  • Diarrhea
rosiglitazone
  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Upset stomach
FAERS Reports
cimetidine
  • Chronic Kidney Disease 1,264
  • Acute Kidney Injury 710
  • Renal Failure 694
  • Nausea 681
  • Fatigue 598
rosiglitazone

No adverse event reports.

Serious Warnings
cimetidine

Reversible confusional states (like mental confusion, agitation, or hallucinations) have been reported, mostly in severely ill patients. These usually appear within 2-3 days of starting treatment and clear up within 3-4 days of stopping the drug.

rosiglitazone

No specific warnings noted.

Pregnancy
cimetidine

Tell your doctor if you are pregnant or plan to become pregnant. The effects of cimetidine during pregnancy are not fully known. Talk to your doctor about the risks and benefits of taking cimetidine while breastfeeding.

rosiglitazone

No pregnancy information available.

Also Compare, Nearby Drugs

How to Read This cimetidine vs rosiglitazone Comparison

cimetidine is classified in the H2 Receptor Antagonist drug class, while rosiglitazone sits within the Thiazolidinedione class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, cimetidine has 3,947 submissions while rosiglitazone has 0. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to cimetidine can interfere with how the body removes the other medication through the kidneys. this happens because both drugs use the same pathway to leave the body.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for cimetidine or rosiglitazone.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.